Filters
Other countries
Results: 1 to 10 of 10
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
HIV infection, susceptibility/resistance to (Response to antiviral treatment in hepatitis C) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hepatitis C virus, resistance to, 609532 (Response to antiviral treatment in hepatitis C) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
West nile virus, susceptibility to, 610379 (West-Nile encephalitis) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
MVZ diagnosticum Frankfurt MVZ diagnosticum GmbH Germany | 46 | 29 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.